Search Results - "Kandane-Rathnayake R"

Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus.

Authors: Kandane-Rathnayake, R Kent, J R Louthrenoo, W et al.

Source: Lupus. Dec2019, Vol. 28 Issue 14, p1669-1677. 9p. 2 Diagrams, 4 Charts.

Day or overnight transfusion in critically ill patients: does it matter?

Authors: Aubron, C. Kandane‐Rathnayake, R. K. Andrianopoulos, N. et al.

Source: Vox Sanguinis. Apr2018, Vol. 113 Issue 3, p275-282. 8p. 4 Charts.

Validation of the Lupus Impact Tracker in an Australian patient cohort.

Authors: Antony, A. Kandane-Rathnayake, R. K. Ko, T. et al.

Source: Lupus. Jan2017, Vol. 26 Issue 1, p98-105. 8p. 3 Charts, 1 Graph.

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.

Authors: Vincent, F. B. Kandane-Rathnayake, R. Hoi, A. Y. et al.

Source: Lupus. 12/15/2018, Vol. 27 Issue 13, p2029-2040. 12p. 5 Charts, 1 Graph.

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.

Authors: Connelly, K. L. Kandane-Rathnayake, R. Hoi, A. et al.

Source: Scientific Reports. 7/29/2016, p29909. 1p.

Résultats jusqu'à 12 mois d'une étude phase 1/2 évaluant la tolérance, la cinétique cellulaire et l'efficacité du rapcabtagene autoleucel (YTB323) un CAR-T ciblant le CD19 de fabrication rapide, dans le lupus érythémateux systémique sévère réfractaire

Authors: Amoura, Z. Morand, E. Kandane-Rathnayake, R. et al.

Source: Revue du Rhumatisme. 2025 Supplement 1, Vol. 92, pA145-A146. 2p.

Mould-sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens.

Authors: Matheson, M. C. Reece, J. C. Kandane‐Rathnayake, R. K. et al.

Source: Allergy. Dec2016, Vol. 71 Issue 12, p1701-1711. 11p. 1 Diagram, 3 Charts, 3 Graphs.

Discordance of patient and physician health status concerns in systemic lupus erythematosus.

Authors: Golder, V. Ooi, J. J. Y. Antony, A. S. et al.

Source: Lupus. Mar2018, Vol. 27 Issue 3, p501-506. 6p. 2 Charts, 1 Graph.

Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypes.

Authors: Eades LE Papadaki A Lennard K et al.

Source: RMD open [RMD Open] 2026 Jul 15; Vol. 12 (3). Date of Electronic Publication: 2026 Jul 15.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE

Modeling SLE Treatment Cost-Effectiveness Based on a Novel LLDAS Treat-to-Target Approach.

Authors: Farris M Christensen J Golder V et al.

Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2026 Jul 14. Date of Electronic Publication: 2026 Jul 14.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study.

Authors: Zolio L Hao Y Kandane-Rathnayake R et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Jun 03; Vol. 65 (6).

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data.

Authors: Lin A Kandane-Rathnayake R Morand EF et al.

Source: Lupus science & medicine [Lupus Sci Med] 2026 May 21; Vol. 13 (1). Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort study.

Authors: Kandane-Rathnayake R Koelmeyer R Oon S et al.

Source: Arthritis research & therapy [Arthritis Res Ther] 2026 May 11; Vol. 28 (1). Date of Electronic Publication: 2026 May 11.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort.

Authors: Kandane-Rathnayake R Louthrenoo W Lau CS et al.

Source: Arthritis research & therapy [Arthritis Res Ther] 2025 Jul 23; Vol. 27 (1), pp. 155. Date of Electronic Publication: 2025 Jul 23.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study.

Authors: Kandane-Rathnayake R Golder V Louthrenoo W et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 May 01; Vol. 64 (5), pp. 2741-2748.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network.

Authors: Zazzetti F Orillion A Sbarigia U et al.

Source: Lupus science & medicine [Lupus Sci Med] 2026 Apr 10; Vol. 13 (1). Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study.

Authors: Saracino AM Hao Y Hansen D et al.

Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2026 Apr 06. Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE

Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study.

Authors: Kent J Xu X Ramnarain A et al.

Source: Arthritis research & therapy [Arthritis Res Ther] 2026 Mar 18; Vol. 28 (1). Date of Electronic Publication: 2026 Mar 18.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active.

Authors: Hao Y Hansen D Kandane-Rathnayake R et al.

Corporate Authors: Hao Y Hansen D Kandane-Rathnayake R et al.

Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2026 Mar; Vol. 78 (3), pp. 378-387. Date of Electronic Publication: 2025 Dec 29.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE

Predictors of damage accrual by organ domain in systemic lupus erythematosus.

Authors: Kandane-Rathnayake R Zolio L Choi JI et al.

Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Feb 04; Vol. 65 (2).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE; In Process